Top-Rated Analysts

Cantor Comments On Alibaba Following Earnings Release; Raises PT To $110

In a research report released earlier today, Cantor analyst Youssef Squali maintained a Buy rating on Alibaba Group (NYSE:BABA) with a $110 price …

Oppenheimer Comments On Intercept As FLINT Manuscript Has Been Accepted For Publication In A Journal

Oppenheimer analyst Akiva Felt maintained an Outperform rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as a webpage from Johns Hopkins School of Public Health states that …

Cantor Maintains Buy On Shutterstock Shares, Sees 21% Upside

In a research report released today, Cantor analyst Youssef Squali maintained a Buy rating on Shutterstock (NYSE:SSTK) with a price target of $95, which …

Steady Improvement Likely To Persist In 3Q Results, Says Cantor

In a research report issued today, Cantor analyst Youssef Squali assigned a Buy rating on AOL Inc (NYSE:AOL) with a price target of …

We Continue To See Significant Upside Remaining In Broadcom Shares, Says Deutsche Bank

In a research note sent to investors today, Deutsche Bank analyst Ross Seymore reiterated a Buy rating on Broadcom (NASDAQ:BRCM) with a price …

Cantor Remains Bullish On LinkedIn On The Back Of Strong 3Q14 Results; Raises PT To $255

In a research report issued this morning, Cantor analyst Youssef Squali maintained a Buy rating on LinkedIn Corp (NYSE:LNKD) and slightly raised his …

Deutsche Bank Becomes Bullish On Alibaba Shares; Sees 15% Upside For The Stock

In a research report issued today, Deutsche Bank analyst Alan Hellawell initiated coverage on Alibaba Group (NYSE:BABA) with a Buy rating and a $112.70 …

Oppenheimer Reiterates Outperform On Shares Of Dyax, Raises PT To $14

Oppenheimer analyst Akiva Felt reiterated an Outperform rating on Dyax Corp (NASDAQ:DYAX) and slightly raised his price target to $14 (from $13). Felt noted, …

Oppenheimer Maintains Outperform On Zogenix Following Acquisition Of Brabant Pharma

In a research report issued Tuesday, Oppenheimer analyst Akiva Felt maintained an Outperform rating on Zogenix (NASDAQ:ZGNX) with a price target of $2.50, …

UPDATE: Cantor Remain Buyers Of Twitter Following Earnings

In a research report released Tuesday, Cantor analyst Youssef Squali assigned a Buy rating on Twitter Inc (NYSE:TWTR) with a $58 price target, as the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts